TIL Therapy: A New Melanoma Treatment 30 Years in the Making
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
The AACR-Women in Cancer Research constituency group celebrates its 25th anniversary this year.
Dr. Alan D’Andrea spoke about a new grant looking for fresh perspectives in Fanconi anemia-related cancer research.
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
Lesbian, gay, bisexual, and transgender (LGBT) people may be at increased risk of certain cancers.
A young adult shares his story of leaving college and learning to rely on his mother as he battled...
The story is familiar: A patient is diagnosed with cancer, they begin treatment, and, after a few months, they...
Two graduates of the AACR Scientist↔Survivor Program, a special educational experience that gives patient advocates the opportunity to attend...
Sara Hanna Velarde, PhD, began her career in cancer research as a graduate student at the University of North...
Like most cancers, colorectal cancer (CRC) is easier to treat before it spreads to other organs. When caught in its earliest stages, the five-year relative...
After being diagnosed with stage 4 stomach cancer, Debbie Zelman, Esq., started Debbie’s Dream Foundation: Curing Stomach Cancer (DDF)...
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
When a patient receives a cancer diagnosis, doctors may perform genetic testing to determine what drives the cancer, potentially...
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...
The AACR’s Global Scholar-In-Training Award program provides highly talented researchers from LMIC countries with the opportunity to acquire additional...
In 2021, Lillian L. Siu, MD, and Elaine R. Mardis, PhD, FAACR, each received a call from AACR Chief...
Bacteria account for over 75% of the Earth’s population. And while we often think of these microbes as something...
Immunotherapy is a form of cancer treatment that helps a patient’s own immune system recognize and attack cancer cells....
Although a basic assumption of genetics is that all the cells in our body share the same DNA, research...
In the United States, advances in cancer research have dramatically improved outcomes for children diagnosed with cancer. While pediatric...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
Last week, we launched a new logo and brand identity for the American Association for Cancer Research (AACR) and...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Cancers that grow and disseminate to threaten life reside...
When the AACR Annual Meeting 2015 begins April 18 in Philadelphia, more than 18,500 attendees will flow seamlessly through...
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
For October’s installment of Editors’ Picks, the AACR journal editors have selected studies that feature results from two phase...
Each month, the editors of the nine AACR journals select one article from each issue to highlight. The featured articles for September described the preclinical evaluation...
For September, the editors of the nine AACR journals have chosen to highlight a clinical trial that evaluated an Hsp90 inhibitor for...
T-DM1, a HER2-targeted antibody-drug conjugate, improved outcomes for patients with HER2-positive, metastatic breast cancer that had progressed despite prior...